MIRA Pharmaceuticals (MIRA) Competitors $1.87 +0.21 (+12.65%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$1.88 +0.01 (+0.80%) As of 05:17 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MIRA vs. PLRX, ZURA, EPIX, QNCX, SRZN, INCR, IMMX, ABOS, IMUX, and GNTAShould you be buying MIRA Pharmaceuticals stock or one of its competitors? The main competitors of MIRA Pharmaceuticals include Pliant Therapeutics (PLRX), Zura Bio (ZURA), ESSA Pharma (EPIX), Quince Therapeutics (QNCX), Surrozen (SRZN), InterCure (INCR), Immix Biopharma (IMMX), Acumen Pharmaceuticals (ABOS), Immunic (IMUX), and Genenta Science (GNTA). These companies are all part of the "pharmaceutical products" industry. MIRA Pharmaceuticals vs. Its Competitors Pliant Therapeutics Zura Bio ESSA Pharma Quince Therapeutics Surrozen InterCure Immix Biopharma Acumen Pharmaceuticals Immunic Genenta Science Pliant Therapeutics (NASDAQ:PLRX) and MIRA Pharmaceuticals (NASDAQ:MIRA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability. Which has better valuation & earnings, PLRX or MIRA? MIRA Pharmaceuticals is trading at a lower price-to-earnings ratio than Pliant Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPliant TherapeuticsN/AN/A-$210.30M-$3.61-0.37MIRA PharmaceuticalsN/AN/A-$7.85M-$0.51-3.67 Is PLRX or MIRA more profitable? Pliant Therapeutics' return on equity of -67.56% beat MIRA Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Pliant TherapeuticsN/A -67.56% -52.54% MIRA Pharmaceuticals N/A -341.08%-272.93% Do analysts rate PLRX or MIRA? Pliant Therapeutics presently has a consensus target price of $13.31, suggesting a potential upside of 893.47%. MIRA Pharmaceuticals has a consensus target price of $14.00, suggesting a potential upside of 648.66%. Given Pliant Therapeutics' higher possible upside, analysts clearly believe Pliant Therapeutics is more favorable than MIRA Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pliant Therapeutics 0 Sell rating(s) 12 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00MIRA Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Do institutionals & insiders believe in PLRX or MIRA? 97.3% of Pliant Therapeutics shares are held by institutional investors. Comparatively, 35.2% of MIRA Pharmaceuticals shares are held by institutional investors. 8.0% of Pliant Therapeutics shares are held by company insiders. Comparatively, 6.7% of MIRA Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility and risk, PLRX or MIRA? Pliant Therapeutics has a beta of 1.3, meaning that its stock price is 30% more volatile than the S&P 500. Comparatively, MIRA Pharmaceuticals has a beta of 1.72, meaning that its stock price is 72% more volatile than the S&P 500. Does the media favor PLRX or MIRA? In the previous week, MIRA Pharmaceuticals had 1 more articles in the media than Pliant Therapeutics. MarketBeat recorded 3 mentions for MIRA Pharmaceuticals and 2 mentions for Pliant Therapeutics. Pliant Therapeutics' average media sentiment score of 1.81 beat MIRA Pharmaceuticals' score of 0.96 indicating that Pliant Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pliant Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive MIRA Pharmaceuticals 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryPliant Therapeutics and MIRA Pharmaceuticals tied by winning 7 of the 14 factors compared between the two stocks. Get MIRA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MIRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MIRA vs. The Competition Export to ExcelMetricMIRA PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$28.09M$2.90B$5.51B$9.31BDividend YieldN/A2.46%4.25%4.09%P/E Ratio-3.6720.3628.1219.69Price / SalesN/A298.74439.46100.25Price / CashN/A42.3835.5357.53Price / Book14.387.768.235.67Net Income-$7.85M-$55.11M$3.23B$257.51M7 Day Performance55.83%0.19%-0.52%-0.16%1 Month Performance46.09%10.80%6.71%9.89%1 Year Performance128.02%-0.68%27.10%15.08% MIRA Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MIRAMIRA Pharmaceuticals2.454 of 5 stars$1.87+12.7%$14.00+648.7%+130.9%$28.09MN/A-3.672PLRXPliant Therapeutics4.4697 of 5 stars$1.18-6.3%$13.31+1,028.2%-90.1%$77.35M$1.58M-0.3390ZURAZura Bio2.8492 of 5 stars$1.10-2.7%$14.33+1,203.0%-66.1%$77.26MN/A-1.573EPIXESSA Pharma1.0082 of 5 stars$1.70-2.3%$2.00+17.6%-66.3%$77.24MN/A-2.7050QNCXQuince Therapeutics3.1156 of 5 stars$1.63+1.2%$8.00+390.8%+124.0%$73.21MN/A-1.1760News CoverageSRZNSurrozen2.7563 of 5 stars$8.35-0.1%$38.50+361.1%-11.6%$71.58M$10.65M-0.3380News CoveragePositive NewsINCRInterCure0.5624 of 5 stars$1.50-3.8%N/A-37.8%$71.09M$238.85M0.00350News CoveragePositive NewsHigh Trading VolumeIMMXImmix Biopharma3.5615 of 5 stars$2.62+2.7%$7.00+167.2%+43.9%$71.09MN/A-3.749ABOSAcumen Pharmaceuticals2.988 of 5 stars$1.16flat$6.33+446.0%-56.2%$70.26MN/A-0.6020IMUXImmunic2.4985 of 5 stars$0.77+5.2%$11.60+1,416.3%-39.5%$69.68MN/A-0.6270GNTAGenenta Science2.6121 of 5 stars$3.98+4.7%$25.00+528.1%+3.4%$69.50MN/A0.007Gap Up Related Companies and Tools Related Companies Pliant Therapeutics Competitors Zura Bio Competitors ESSA Pharma Competitors Quince Therapeutics Competitors Surrozen Competitors InterCure Competitors Immix Biopharma Competitors Acumen Pharmaceuticals Competitors Immunic Competitors Genenta Science Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MIRA) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MIRA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MIRA Stock Alerts